As expected, the SCLC patients exhibited significantly higher serum levels of NSE (median 27.2 ng/ml) and ProGRP (median 331.5 pg/ml) than the patients with sarcoidosis or nonsarcoidotic benign diseases. The gene discussed is ENO2; the disease is small cell lung carcinoma.